Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages

  Ferraz, Carolina ^a,b   Lorenz, Stephan ^a   Wojtas, Bartosz ^c   Bornstein, Stefan R ^b   Paschke, Ralf ^a   Eszlinger, Markus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7C; LET 7D; LET 7F; MICRORNA; MICRORNA 130B; MICRORNA 133; MICRORNA 139 5P; MICRORNA 144 5P; MICRORNA 199A 3P; MICRORNA 199B 5P; MICRORNA 218; MICRORNA 22; MICRORNA 221; MICRORNA 31; MICRORNA 365; MICRORNA 374B; MICRORNA 515 3P; MICRORNA 516A 3P; MICRORNA 520A 3P; MICRORNA 548D 5P; MICRORNA 59; MICRORNA 590 3P; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CCND1 GENE; CDKN1A GENE; CDKN1C GENE; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; CELL STRAIN FTC 133; CELL STRAIN HTORI; COLD AND BENIGN THYROID NODULE; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GADD45A GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NECROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID NODULE; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; GENES, CDC; HUMANS; MICRORNAS; RNA, MESSENGER; THYROID NEOPLASMS; THYROID NODULE; TRANSCRIPTOME; VALIDATION STUDIES AS TOPIC;

EID: 84872082092     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2564     Document Type: Article

References (45)

1. AACE/AME Task Force on Thyroid Nodules 2006 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102
2. Hegedüs L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771
3. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369
4. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jørgensen T 2000 Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224-230
5. Patton JA, Sandler MP, Partain CL 1985 Prediction of benignancy of the solitary "cold" thyroid nodule by fluorescent scanning. J Nucl Med 26:461-464
6. Krohn K, Stricker I, Emmrich P, Paschke R 2003 Cold thyroid nodules show a marked increase in proliferation markers. Thyroid 13:569-575
7. Krohn K, Emmrich P, Ott N, Paschke R 1999 Increased thyroid epithelial cell proliferation in toxic thyroid nodules. Thyroid 9:241-246
8. Neumann S, Schuchardt K, Reske A, Reske A, Emmrich P, Paschke R 2004 Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules. Thyroid 14:99-111
9. Eszlinger M, Krohn K, Berger K, Läuter J, Kropf S, Beck M, Führer D, Paschke R 2005 Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163-1170
10. Ambros V 2001 microRNAs: tiny regulators with great potential. Cell 107:823-826
11. Croce CM, Calin GA 2005 miRNAs, cancer, and stem cell division. Cell 122:6-7
12. Png KJ, Halberg N, Yoshida M, Tavazoie SF 2012 A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190-194
13. Bartel DP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
14. Nikiforova MN, Chiosea SI, Nikiforov YE 2009 MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20:85-91
15. Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E 2012 MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118:3426-3432
16. Cowland JB, Hother C, Grønbaek K 2007 MicroRNAs and cancer. APMIS 115:1090-1106
17. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075-19080
18. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497-508
19. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163-173
20. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C 2006 A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91:3584-3591
21. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590-7595
22. Piana S, Frasoldati A, Ferrari M, Valcavi R, Froio E, Barbieri V, Pedroni C, Gardini G 2011 Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998-2007. Cytopathology 22:164-173
23. Ferraz C, Eszlinger M, Paschke R 2011 Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 96:2016-2026
24. Pfaffl MW, Horgan GW, Dempfle L 2002 Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
25. Lemoine NR, Mayall ES, Jones T, Sheer D, McDermid S, Kendall-Taylor P, Wynford-Thomas D 1989 Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer 60:897-903
26. Goretzki PE, Frilling A, Simon D, Roeher HD 1990 Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res 118:48-63
27. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, García-Foncillas J 2006 Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29
28. Li X, Zhang G, Luo F, Ruan J, Huang D, Feng D, Xiao D, Zeng Z, Chen X, Wu W 2012 Identification of aberrantly expressed miRNAs in rectal cancer. Oncol Rep 28:77-84
29. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, Lu SH 2011 The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) 121:437-447
30. Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, Hoyt K, Szpakowski S, Godshalk S, Ariyan S, Sznol M, Halaban R, Krauthammer M, Tuck D, Slack FJ, Weidhaas JB 2011 MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10:1845-1852
31. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA 2011 Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 25:646-659
32. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K 2010 Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126:1166-1176
33. Zhang Y, Guo J, Li D, Xiao B, Miao Y, Jiang Z, Zhuo H 2010 Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol 27:685-689
34. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E 2010 MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120:1298-1309
35. Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN 2011 MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18:2035-2041
36. Roger PP, van Staveren WC, Coulonval K, Dumont JE, Maenhaut C 2010 Signal transduction in the human thyrocyte and its perversion in thyroid tumors. Mol Cell Endocrinol 321:3-19
37. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C 2000 Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 6:1891-1895
38. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE, Reifenberger G 2010 Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20:539-550
39. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT 2008 Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 68:8976-8985
40. Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, Soong R 2010 MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 46:1456-1463
41. Lowe SW, Lin AW 2000 Apoptosis in cancer. Carcinogenesis 21:485-495
42. Chen YT, Kitabayashi N, Zhou XK, Fahey 3rd TJ, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139-1146
43. Kim HJ, Chung JK, Hwang do W, Lee DS, Kim S 2009 In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Mol Imaging Biol 11:71-78
44. Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P 2011 Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? Endocr Relat Cancer 18:579-594
45. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, Mitrani-Rosenbaum S, Roistacher M, Ariel I, Eid A, Freund HR, Nissan A 2011 Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21:111-118